SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049966
Filing Date
2024-04-29
Accepted
2024-04-29 16:40:03
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A lctx_proxy_2024_-_naa.htm DEFA14A 23015
2 GRAPHIC img224236018_0.jpg GRAPHIC 1193591
3 GRAPHIC img224236018_1.jpg GRAPHIC 111736
  Complete submission text file 0000950170-24-049966.txt   1820266
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-12830 | Film No.: 24891868
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)